ADI welcomes positive results from new drug trial for Alzheimer’s Disease

27 July 2016 - ADI welcomes the announcement of Phase 3 clinical trial results today that show the beneficial effect on key measures of Alzheimer’s Disease of the drug LMTM by TauRx Therapeutics. [read more]

World rocks against dementia again in 2017

11 July 2016 - Executie Director Marc Wortmann wrote the following message to encourage support for next year's World Rocks Against Dementia (WRAD) in March 2017. [read more]

Prof Henry Brodaty awarded Ryman Prize

22 June 2016 - ADI Honorary Vice President Prof Henry Brodaty has been awarded the international Ryman Prize for his tireless efforts in dementia research over the last 30 years. [read more]

Syndicate content